Clinicians should be more familiar with typical features of these conditions and aware of important differential diagnosis, which contributes to obtaining an early final diagnosis
The phase 2 clinical trial data, published in The Lancet Diabetes and Endocrinology, tells a more nuanced story than the headlines suggest
Underground sources exist but carry quality and legal risks
PubMed Central, Jarvela, Timothy S., et al
Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: a real-world retrospective study
The Diabetes Prevention Program and Look AHEAD trials demonstrated that intensive lifestyle interventions produce clinically meaningful metabolic improvements, and these effects are additive with pharmacotherapy